167 related articles for article (PubMed ID: 18955802)
1. Acute drug-induced hepatitis caused by albendazole.
Choi GY; Yang HW; Cho SH; Kang DW; Go H; Lee WC; Lee YJ; Jung SH; Kim AN; Cha SW
J Korean Med Sci; 2008 Oct; 23(5):903-5. PubMed ID: 18955802
[TBL] [Abstract][Full Text] [Related]
2. Albendazole Induced Recurrent Acute Toxic Hepatitis: A Case Report.
Bilgic Y; Yilmaz C; Cagin YF; Atayan Y; Karadag N; Harputluoglu MMM
Acta Gastroenterol Belg; 2017; 80(2):309-311. PubMed ID: 29560698
[TBL] [Abstract][Full Text] [Related]
3. Albendazole-induced toxic hepatitis: A case report.
Gözüküçük R; Abci İ; Güçlü M
Turk J Gastroenterol; 2013; 24(1):82-4. PubMed ID: 23794356
[No Abstract] [Full Text] [Related]
4. A detection algorithm for drug-induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method scale.
Hanatani T; Sai K; Tohkin M; Segawa K; Kimura M; Hori K; Kawakami J; Saito Y
Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):984-8. PubMed ID: 24596340
[TBL] [Abstract][Full Text] [Related]
5. [Drug Induced Liver Injury by Prophylactic Administration of Albendazole].
Moon SY; Baek YH; Lee SW
Korean J Gastroenterol; 2019 Jun; 73(6):360-364. PubMed ID: 31234627
[TBL] [Abstract][Full Text] [Related]
6. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?
Danan G; Teschke R
Drug Saf; 2018 Aug; 41(8):735-743. PubMed ID: 29502198
[TBL] [Abstract][Full Text] [Related]
7. Montelukast induced acute hepatocellular liver injury.
Harugeri A; Parthasarathi G; Sharma J; D'Souza GA; Ramesh M
J Postgrad Med; 2009; 55(2):141-2. PubMed ID: 19550064
[TBL] [Abstract][Full Text] [Related]
8. Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection.
Carrascosa MF; Lucena MI; Andrade RJ; Caviedes JR; Lavín AC; Mones JC; Rivero AP; Serrano VB
Clin Ther; 2009 May; 31(5):1014-9. PubMed ID: 19539102
[TBL] [Abstract][Full Text] [Related]
9. Drug-Induced Liver Failure Requiring Liver Transplant: Report and Review of the Role of Albendazole in Managing Echinococcal Infection.
Aasen TD; Nasrollah L; Seetharam A
Exp Clin Transplant; 2018 Jun; 16(3):344-347. PubMed ID: 27228108
[TBL] [Abstract][Full Text] [Related]
10. Recurrent acute hepatitis caused by albendazole.
Shah C; Mahapatra A; Shukla A; Bhatia S
Trop Gastroenterol; 2013; 34(1):38-9. PubMed ID: 23923374
[No Abstract] [Full Text] [Related]
11. [Acute hepatitis as a side effect of albendazole: a pediatric case].
Amoruso C; Fuoti M; Miceli V; Zito E; Celano MR; De Giorgi A; Nebbia G
Pediatr Med Chir; 2009; 31(6):262-4. PubMed ID: 20333886
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury.
García-Cortés M; Lucena MI; Pachkoria K; Borraz Y; Hidalgo R; Andrade RJ;
Aliment Pharmacol Ther; 2008 May; 27(9):780-9. PubMed ID: 18284654
[TBL] [Abstract][Full Text] [Related]
13. Acute hepatitis in a paediatric patient: immune-mediated drug-induced liver injury or albendazole-induced autoimmune hepatitis?
Dragutinović N; Barać A; Stevanović G; Đorđić I; Paglietti B; Micić J; Aleksić E; Stojnić J; Martinov Nestorov J
J Infect Dev Ctries; 2022 Oct; 16(10):1660-1663. PubMed ID: 36332223
[TBL] [Abstract][Full Text] [Related]
14. [Acute hepatitis as a side effect of albendazole: a pediatric case].
Amoruso C; Fuoti M; Miceli V; Zito E; Celano MR; De Giorgi A; Nebbia G
Pediatr Med Chir; 2009; 31(4):176-8. PubMed ID: 19839402
[TBL] [Abstract][Full Text] [Related]
15. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of an international consensus meeting.
Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):317-22. PubMed ID: 2272712
[TBL] [Abstract][Full Text] [Related]
16. Causality assessment methods in drug induced liver injury: strengths and weaknesses.
García-Cortés M; Stephens C; Lucena MI; Fernández-Castañer A; Andrade RJ
J Hepatol; 2011 Sep; 55(3):683-691. PubMed ID: 21349301
[TBL] [Abstract][Full Text] [Related]
17. [Two cases of toxic hepatitis caused by arrowroot juice].
Kim SY; Yim HJ; Ahn JH; Kim JH; Kim JN; Yoon I; Kim DI; Lee HS; Lee SW; Choi JH
Korean J Hepatol; 2009 Dec; 15(4):504-9. PubMed ID: 20037269
[TBL] [Abstract][Full Text] [Related]
18. Albendazole-induced associated acute hepatitis and bicytopenia.
Ben Fredj N; Chaabane A; Chadly Z; Ben Fadhel N; Boughattas NA; Aouam K
Scand J Infect Dis; 2014 Feb; 46(2):149-51. PubMed ID: 24423162
[TBL] [Abstract][Full Text] [Related]
19. The predictors of complications in patients with drug-induced liver injury caused by antimicrobial agents.
Treeprasertsuk S; Huntrakul J; Ridtitid W; Kullavanijaya P; Björnsson ES
Aliment Pharmacol Ther; 2010 Jun; 31(11):1200-7. PubMed ID: 20222907
[TBL] [Abstract][Full Text] [Related]
20. Albendazole-induced granulomatous hepatitis: a case report.
Marin Zuluaga JI; Marin Castro AE; Perez Cadavid JC; Restrepo Gutierrez JC
J Med Case Rep; 2013 Jul; 7():201. PubMed ID: 23889970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
